New York, NY (PRWEB) April 20, 2017
Cohero Health a digital health company that is transforming respiratory disease management through smart mobile technology, has named Joe Condurso as its new Chief Executive Officer. Condurso will lead the next stage of Cohero’s growth and expansion.
Cohero has pioneered the integration of medical devices, mobile technology, and software to help people with respiratory ailments measure lung function, track medication usage, and connect with their doctor, empowering patients to better manage their conditions.
“Cohero is redefining the standard of care in respiratory therapy, and founders Melissa Manice and Dan Weinstein have done an exceptional job developing a ground-breaking, tech-enabled solution to help people with asthma and other respiratory issues live healthier lives,” said Steve Agular, member of the Cohero Board of Directors and Managing Director of Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts. “Joe has the perfect background and experience to build on this great foundation and propel the company to the next level.”
“We are pleased to welcome Joe to the talented team at Cohero Health,” said Melissa Manice, PhD, Co-founder and President of Cohero. “We all share a deep passion for the use of technology to improve health care and patient quality of life, and I look forward to working with Joe to advance Cohero’s leadership position and strategic direction.”
Condurso has 30 years of experience in the health care industry, conceptualizing and commercializing first of its kind medical technologies and services. Most recently, he served as CEO of PatientSafe Solutions, repositioning the company and expanding its product offerings to become a market leader in SaaS network solutions for smart interactive workflow and care coordination, and leading the company through $35 million in strategic and growth capital raises. Before that, Condurso was Vice President, leading strategy, innovation, and business development at CareFusion Corp, now Becton Dickinson. Condurso also spent a decade in leadership roles at companies that became part of Cardinal Health, was Co-founder and Chief Operating Officer of iMetrikus Inc., and held a number of executive leadership roles at Chiron Corp, Motorola, and Draeger Medical Systems, Inc.
“Cohero’s suite of interactive, tech-enabled solutions are already having a positive impact on the health of people with respiratory disease improving patient engagement, treatment compliance and medication adherence,” said Condurso. “I look forward to working with the board and team of people at Cohero whose intellectual curiosity defines the transformative culture that is leading the way in respiratory disease management.”
About Cohero Health Inc.
Cohero Health is a digital health company developing innovative tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization. The company’s connected devices and mobile applications actively engage and empower respiratory patients by measuring lung function and tracking adherence. Based in New York City, the company is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech. The company’s platform has been used by pulmonary patients in over 25 commercial deployments, reaching over 1 million covered lives. Cohero Health is backed by Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts; Three Leaf Ventures, an affiliate of the Broe Group; BioAdvance; Heitkamp & Thumann Group; Samsung NEXT; Omron Healthcare; GIS Strategic Ventures; and P5 Health Ventures.